| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 3,178,653 | 2,540,485 | | Cost of Revenue | 2,057,647 | 1,718,176 | | | Gross Profit | 1,121,006 | 822,309 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 374,737 | 265,057 | | Non Recurring | 1,183,955 | 108,668 | | Others | 373,602 | 252,716 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (811,288) | 195,868 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 18,760 | (25,504) | | Earnings Before Interest And Taxes | (768,554) | 182,862 | | Interest Expense | 129,723 | 130,092 | | Income Before Tax | (898,277) | 52,770 | | Income Tax Expense | 37,197 | 11,894 | | Minority Interest | (12,273) | (6,307) | | | | Net Income From Continuing Ops | (947,747) | 34,569 | | | Non-recurring Events | | Discontinued Operations | 398 |
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (947,349) | 34,569 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($947,349) | $34,569 |
|
0.15% Nasdaq 
Income Statement
